Georges

Niang

Thanks to a foot injury suffered before the start of training camp, Niang did not play at all in 2025-26 after agreeing to a one-year deal with the Jazz. The veteran forward, who was sent to Memphis as part of the Jaren Jackson Jr. trade, was waived shortly thereafter. Playing for the Cavaliers and Hawks, Niang averaged 9.9 points, 3.4 rebounds, 1.4 assists and 2.1 three-pointers per game in 2024-25, shooting 40.6 percent from beyond the arc. He’ll provide the Warriors with added frontcourt depth but is unlikely to be in a position where he consistently affects fantasy basketball.

The Warriors have roster spots to fill, but not much cap space to do it. Due to a left foot injury, Niang did not play at all in 2025-26, beginning his year with the Jazz before being sent to Memphis as part of the Jaren Jackson Jr. trade. As for Williams, he appeared in 66 games for the Mavericks last season, averaging 13.0 points, 2.9 rebounds, 3.9 assists and 0.9 steals in 22.2 minutes. While he did record career-best averages, Williams’ increased opportunities came as a result of Kyrie Irving missing the entire season with a torn ACL. He and Niang are capable contributors if they were to land with the Warriors, but neither qualifies as a must-draft player in most leagues.

Niang was sent from Utah to Memphis as part of the Jaren Jackson Jr. trade, but the Grizzlies won’t keep him around. The veteran forward will look to find a new team to join for the second half of the season, where he will likely end up as just a depth piece.

Niang, whom the Jazz signed to a one-year deal during the offseason, has yet to appear in a game this season due to a stress reaction in his left foot. His addition to the Grizzlies roster won’t affect fantasy basketball, as he does not have a timeline to return to action.

Sidelined by a stress reaction in the fourth metatarsal of his left foot, Niang has yet to appear in a game this season. According to the Jazz, it will be at least two more weeks before he has the opportunity to play. Niang’s continued absence does not directly affect fantasy basketball, but it does leave more minutes available for some of Utah’s younger frontcourt players.

Niang, who has yet to play a game this season, is dealing with a stress reaction in his left fourth metatarsal. Given the lack of activity, even if he’s given a clean bill of health at the next evaluation, there will likely be a ramp-up period to bring Niang’s conditioning up to par. There’s no need to stash him in an IL slot.

Niang was given a two-week timeline for re-evaluation on September 27, but he’s still not ready to return. The new evaluation on October 12 means he’ll be sidelined through the start of the regular season. Once he’s back on the court, there’s no guarantee Niang will play enough minutes to be a viable fantasy option in 12-team leagues.

Per a team release, Niang suffered a stress reaction in the fourth metatarsal in his left foot during offseason training. As a result, he’ll be sidelined for two weeks before the team’s medical staff re-evaluates the veteran forward’s foot. Niang was traded twice this offseason, first being sent from Atlanta to Boston before the Celtics moved him to Utah. Once healthy, he’ll play rotation minutes, but the question is how much due to Utah being in the midst of a rebuild.

The deal also sends two second-round picks from Boston to Utah as part of the deal. Moving Niang is just a financial move for the Celtics, but his departure thins out Boston’s rotation even further. Sam Hauser and Baylor Scheierman could see more playing time for the depleted Celtics. Niang’s role in Utah is more difficult to forecast, as the Jazz are already deep in the frontcourt.

Niang was traded to Atlanta at the trade deadline last season and immediately provided a veteran presence in the rotation. He had some big nights from beyond the arc, and with Jayson Tatum (Achilles) set to miss at least most of next season, Niang could be part of the rotation in Boston. However, this was simply a move for the Celtics to avoid the second apron.